Vijoice Tablet
RxNorm Crosswalk NDC 0078-1021

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Vijoice (NDC 0078-1021) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 16 unique RxNorm concepts. By anchoring Novartis Pharmaceuticals Corporation's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

alpelisib 200 MG Oral Tablet
(RxCUI 2169310)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

alpelisib 50 MG Oral Tablet
(RxCUI 2169316)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

alpelisib 200 MG (28) Oral Tablet / alpelisib 50 MG Oral Tablet (28) Oral Tablet, 250 MG Daily Dose Pack
(RxCUI 2169319)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Vijoice 50 MG Oral Tablet
(RxCUI 2598459)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

alpelisib 125 MG Oral Tablet
(RxCUI 2598461)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Vijoice 125 MG Oral Tablet
(RxCUI 2598463)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

alpelisib 125 MG Oral Tablet, 28 Day Pack
(RxCUI 2598464)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Vijoice 125 MG 28 Day Pack
(RxCUI 2598465)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

alpelisib 50 MG 28 Day Pack
(RxCUI 2598466)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Vijoice 50 MG 28 Day Pack
(RxCUI 2598467)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Vijoice 200 MG Oral Tablet
(RxCUI 2598469)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Vijoice 250 MG 28 Day Pack
(RxCUI 2598470)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

alpelisib 50 MG Oral Granules
(RxCUI 2680135)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Vijoice 50 MG Oral Granules
(RxCUI 2680138)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

alpelisib 50 MG Oral Granules 28 Day Pack
(RxCUI 2680139)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Vijoice 50 MG Oral Granules 28 Day Pack
(RxCUI 2680140)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Vijoice

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 0078-1021 to RxCUI 2169310, 2169316, 2169319, 2598459, 2598461, 2598463, 2598464, 2598465, 2598466, 2598467, 2598469, 2598470, 2680135, 2680138, 2680139, 2680140, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • GPCK Generic Pack: A standardized concept for a clinical kit containing multiple generic components.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • BPCK Branded Pack: A standardized concept for a clinical kit containing multiple branded components.

* Please review the full disclaimer at the bottom of this page.